Inovio Pharmaceuticals(INO) - 2024 Q3 - Quarterly Results

Exhibit 99.1 INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights – New immunology data for INO-3107 supporting proposed mechanism of action presented at several recent conferences • Data showed ability of INO-3107 to induce an antigen-specific cytotoxic T cell response against HPV-6 and HPV-11 and drive recruitment of T cells into airway tissues and papilloma • Data showed INO-3107 induced expansion of new clonal T cells that infiltrate airway tissues and correspond with reduc ...